119 related articles for article (PubMed ID: 6970035)
1. An assay of deoxyadenosine and adenosine in human plasma by HPLC.
Koller CA; Stetson PL; Nichamin LD; Mitchell BS
Biochem Med; 1980 Oct; 24(2):179-84. PubMed ID: 6970035
[No Abstract] [Full Text] [Related]
2. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
Venner PM; Glazer RI; Blatt J; Sallan S; Rivera G; Holcenberg JS; Lipton J; Murphy SB; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4508-11. PubMed ID: 6975654
[TBL] [Abstract][Full Text] [Related]
3. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
4. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of deoxycoformycin.
Major PP; Agarwal RP; Kufe DW
Blood; 1981 Jul; 58(1):91-6. PubMed ID: 6263381
[TBL] [Abstract][Full Text] [Related]
6. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
Kefford RF; Fox RM
Cancer Chemother Pharmacol; 1983; 10(2):73-8. PubMed ID: 6600985
[No Abstract] [Full Text] [Related]
7. Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
Deibel MR; Coleman MS; Hutton JJ
Biochem Med; 1981 Jun; 25(3):288-97. PubMed ID: 6973972
[No Abstract] [Full Text] [Related]
8. Inhibition of 3H-thymidine incorporation by adenosine and deoxyadenosine in human peripheral lymphocytes and malignant lymphoid cell lines.
van der Krann PM; van Zandvoort PM; De Abreu RA; Bakkeren JA; van Laarhoven JP; de Bruijn CH
Adv Exp Med Biol; 1986; 195 Pt B():213-9. PubMed ID: 3490120
[No Abstract] [Full Text] [Related]
9. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
Kefford RF; Fox RM
Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
[TBL] [Abstract][Full Text] [Related]
10. Renal handling of 2'-deoxyadenosine and adenosine in humans and mice.
Kuttesch JF; Nelson JA
Cancer Chemother Pharmacol; 1982; 8(2):221-9. PubMed ID: 6980741
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.
Major PP; Agarwal RP; Kufe DW
Cancer Chemother Pharmacol; 1983; 10(2):125-8. PubMed ID: 6600984
[No Abstract] [Full Text] [Related]
12. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase.
Webster DR; Simmonds HA; Perrett D; Levinsky RJ
Adv Exp Med Biol; 1984; 165 Pt A():363-6. PubMed ID: 6609529
[No Abstract] [Full Text] [Related]
14. Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells.
Koller CA; Orringer EP; Berkowitz LR; Mulhern AT
Prog Clin Biol Res; 1984; 165():227-39. PubMed ID: 6334314
[No Abstract] [Full Text] [Related]
15. Treatment of multiple myeloma with deoxycoformycin.
Belch AR; Henderson JF; Brox LW
Cancer Chemother Pharmacol; 1985; 14(1):49-52. PubMed ID: 3871175
[TBL] [Abstract][Full Text] [Related]
16. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; PĂ©rignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Kang GJ; Kimball AP
Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo.
Mitchell BS; Koller CA; Heyn R
Blood; 1980 Sep; 56(3):556-9. PubMed ID: 6967747
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Mitchell BS; Koller CA; Kelley WN
Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]